retatrutide clinical trial results safety Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Retatrutide vs Tirzepatide (2026): Differences

For many women, metabolic health changes with age

Adjusted PAT for the year surged 50% to 10,455 million, with Q4 adjusted PAT rising 97% to 3,667 million

These days, it can feel like everyones using and talking about GLP-1 weight loss medications

Accessing effective weight loss treatments no longer requires multiple office visits, complicated insurance approvals, or trips to the pharmacy

Obesity significantly impacts gut microbial composition, exacerbating metabolic dysfunction and weight gain

This gentle daily supplement supports steady digestion, regularity, and microbiome health as your body adjusts to new eating patterns